Line 1: |
Line 1: |
− | [[B-ALL|ALL]] | + | Immunoglobulin locus rearrangements occur in tumors arising from the B-cell lineage [[B-ALL|ALL]], [[Lymphoma]] and [[Multiple Myeloma]]. |
− | [[Lymphoma]] | + | IGH/K/L partner genes are numerous and include: |
− | [[Multiple Myeloma]] | + | *BCL11B |
− | BCL11B | + | *BACH2 |
− | BACH2 | + | *CCND1 |
− | CCND1 | + | *BCL2 |
− | BCL2 | + | *BANK1 |
− | BANK1 | + | *CCND3 |
− | CCND3 | + | *CCND2 |
− | CCND2 | + | *BCL10 |
− | BCL10 | + | *FGFR3 |
− | FGFR3 | + | *CEBPA |
− | CEBPA | + | *BCL11A |
− | BCL11A | + | *IRF4 |
− | IRF4 | + | *CEBPB |
− | CEBPB | + | *BCL2 |
− | BCL2 | + | *MAF |
− | MAF | + | *CEBPD |
− | CEBPD | + | *BCL3 |
− | BCL3 | + | *MAFB |
− | MAFB | + | *CEBPE |
− | CEBPE | + | *BCL6 |
− | BCL6 | + | *MMSET |
− | MMSET | + | *CEBPG |
− | CEBPG | + | *BCL7A |
− | BCL7A | + | *MYC |
− | MYC | + | *CRLF2 |
− | CRLF2 | + | *BCL8 |
− | BCL8 | + | *[[IGH-EPOR|EPOR]] |
− | [[EPOR]] | + | *CBAFA2T3 |
− | CBAFA2T3 | + | *HOXA |
− | HOXA | + | *CCND1 |
− | CCND1 | + | *ID4 |
− | ID4 | + | *CCND2 |
− | CCND2 | + | *IGF2BP1 |
− | IGF2BP1 | + | *CCNE1 |
− | CCNE1 | + | *IL3 |
− | IL3 | + | *CD44 |
− | CD44 | + | *LCK |
− | LCK | + | *CDK6 |
− | CDK6 | + | *LMO1 |
− | LMO1 | + | *CND3 |
− | CND3 | + | *LMO2 |
− | LMO2 | + | *FCGR2A |
− | FCGR2A | + | *LYL1 |
− | LYL1 | + | *FCGR2B |
− | FCGR2B | + | *MYC |
− | MYC | + | *FOXP1 |
− | FOXP1 | + | *NOTCH1 |
− | NOTCH1 | + | *GPR34 |
− | GPR34 | + | *OLIG2 |
− | OLIG2 | + | *IRF4 |
− | IRF4 | + | *TAL1 |
− | TAL1 | + | *IRF8 |
− | IRF8 | + | *TAL2 |
− | TAL2 | + | *IRTA1 |
− | IRTA1 | + | *TCL1 |
− | TCL1 | + | *LHX2 |
− | LHX2 | + | *TLX1 |
− | TLX1 | + | *MALT1 |
− | MALT1 | + | *TLX3 |
− | TLX3 | + | *MUC1 |
− | MUC1 | + | *MYC |
− | MYC | + | *NFKB2 |
− | NFKB2 | + | *PAFAH1A2 |
− | PAFAH1A2 | + | *PAX5 |
− | PAX5 | + | *RCK |
− | RCK | + | *SPIB |
− | SPIB | + | *ZPP36L1 |
− | ZPP36L1 | |